U.S. flag

An official website of the United States government

Format
Items per page
Sort by
Choose Destination

Search results

Items: 1 to 100 of 3113

VariationLocationGene(s)Protein changeCondition(s)Clinical significance
(Last reviewed)
Review status
1.
GRCh37:
Chr10:4646926-47531169
GRCh38:
Chr10:4604734-48074662
ABI1, ACBD5, ACBD7, ACBD7-DCLRE1CP1, AGAP10, AGAP4, AGAP9, AKR1C1, AKR1C2, AKR1C3, AKR1C4, AKR1C8, AKR1E2, ALOX5, ANKRD16, ANKRD26, ANKRD30A, ANTXRL, ANXA8, ANXA8L1, APBB1IP, ARHGAP12, ARHGAP21, ARL5B, ARMC3, ASB13, ATP5F1C, BAMBI, BEND7, BEND7-DT, BMI1, BMS1, C10orf113, C10orf126, C10orf67, C10orf67-AS1, C1QL3, CACNB2, CALML3, CALML3-AS1, CALML5, CAMK1D, CCDC3, CCDC7, CCNY, CDC123, CDNF, CELF2, CELF2-AS1, CELF2-AS2, CELF2-DT, COMMD3, COMMD3-BMI1, CREM, CSGALNACT2, CSGALNACT2-DT, CUBN, CUL2, CXCL12, DCLRE1C, DEPP1, DHTKD1, DNAJC1, EBLN1, ECHDC3, ENKUR, EPC1, EPC1-AS1, FAM107B, FAM171A1, FAM238A, FAM238B, FAM238C, FAM245B, FAM25C, FAM25E, FAM25G, FBH1, FRMD4A, FXYD4, FZD8, GAD2, GATA3, GATA3-AS1, GDF10, GDF2, GDI2, GJD4, GPR158, GPR158-AS1, GPRIN2, HACD1, HNRNPF, HSPA14, IATPR, IL15RA, IL2RA, ITGA8, ITGB1, ITGB1-DT, ITIH2, ITIH5, JCAD, KIAA1217, KIF5B, KIN, LASTR, LINC00619, LINC00705, LINC00706, LINC00707, LINC00708, LINC00709, LINC00710, LINC00836, LINC00837, LINC00838, LINC00839, LINC00840, LINC00841, LINC00842, LINC00993, LINC00999, LINC01264, LINC01516, LINC01517, LINC01518, LINC02561, LINC02623, LINC02628, LINC02629, LINC02630, LINC02632, LINC02634, LINC02637, LINC02642, LINC02643, LINC02644, LINC02648, LINC02649, LINC02652, LINC02654, LINC02656, LINC02658, LINC02659, LINC02664, LINC02665, LINC02670, LINC02673, LINC02676, LINC02677, LINC02678, LINC02881, LINC02916, LINC03027, LINC03028, LINC03029, LINP1, LOC100130992, LOC100505502, LOC101928051, LOC101928272, LOC101928453, LOC101928834, LOC101929073, LOC101929279, LOC101929431, LOC102724323, LOC102724593, LOC105376384, LOC105376387, LOC105376390, LOC105376398, LOC105376420, LOC105378269, LOC105378289, LOC105378577, LOC106736614, LOC106783505, LOC106783576, LOC107001062, LOC107275222, LOC107275223, LOC107275226, LOC108004524, LOC108353817, LOC108353819, LOC108903148, LOC108903149, LOC110121348, LOC110121355, LOC110121399, LOC110121405, LOC110121406, LOC110121476, LOC110121478, LOC110121502, LOC110121503, LOC110121506, LOC110121507, LOC111464994, LOC111501766, LOC111589212, LOC111818964, LOC111818965, LOC111818966, LOC111818967, LOC111946222, LOC111946223, LOC111946224, LOC111946225, LOC111946226, LOC111946227, LOC111946228, LOC111946229, LOC111946230, LOC111946231, LOC111946232, LOC111946234, LOC111946236, LOC111946237, LOC111946238, LOC111946239, LOC111946241, LOC111946242, LOC111946244, LOC111946245, LOC111946246, LOC111946251, LOC111946252, LOC114827857, LOC116216107, LOC116216108, LOC116216109, LOC116216110, LOC116216111, LOC116216112, LOC121366038, LOC121366039, LOC121366040, LOC121366041, LOC121366042, LOC121366043, LOC121366044, LOC121366045, LOC121366046, LOC121366047, LOC121366048, LOC121366049, LOC121366050, LOC121366051, LOC121366052, LOC121366053, LOC121366054, LOC121811723, LOC121811724, LOC121811725, LOC121811726, LOC121811727, LOC121811728, LOC121811729, LOC121811730, LOC124403905, LOC124403906, LOC124403907, LOC124403908, LOC124403909, LOC124403910, LOC124403911, LOC124403912, LOC124403913, LOC124403914, LOC124403915, LOC124403916, LOC124403917, LOC124403918, LOC124403919, LOC124403920, LOC124403921, LOC124403922, LOC124403923, LOC124403924, LOC124403925, LOC124403926, LOC124403927, LOC124403928, LOC124403929, LOC124403930, LOC124403931, LOC124403932, LOC124403933, LOC124403934, LOC124403935, LOC124403936, LOC124403937, LOC124403938, LOC124403939, LOC124403940, LOC124403941, LOC124403942, LOC124403943, LOC124403944, LOC124403945, LOC124403946, LOC124403948, LOC124403949, LOC126860845, LOC126860846, LOC126860847, LOC126860848, LOC126860849, LOC126860850, LOC126860851, LOC126860852, LOC126860853, LOC126860854, LOC126860855, LOC126860856, LOC126860857, LOC126860858, LOC126860859, LOC126860860, LOC126860861, LOC126860862, LOC126860863, LOC126860864, LOC126860865, LOC126860866, LOC126860867, LOC126860868, LOC126860869, LOC126860870, LOC126860871, LOC126860872, LOC126860873, LOC126860874, LOC126860875, LOC126860876, LOC126860877, LOC126860878, LOC126860879, LOC126860880, LOC126860881, LOC126860882, LOC126860883, LOC126860884, LOC126860885, LOC126860886, LOC126860887, LOC126860888, LOC126860889, LOC126860890, LOC126860891, LOC126860892, LOC126860893, LOC126860894, LOC126860895, LOC126860896, LOC126860897, LOC126860898, LOC126860899, LOC126860900, LOC126860901, LOC126860902, LOC126860903, LOC126860904, LOC126860905, LOC126860906, LOC126860907, LOC126860908, LOC126860909, LOC126860910, LOC126860911, LOC126860912, LOC126860913, LOC126860914, LOC126860915, LOC126860916, LOC126860917, LOC126860918, LOC126860919, LOC126860920, LOC126860921, LOC126860922, LOC126860923, LOC126860924, LOC126860925, LOC126860926, LOC126860927, LOC126860928, LOC126860929, LOC128462383, LOC128462384, LOC128462385, LOC128462386, LOC128462408, LOC283028, LYZL1, LYZL2, MACORIS, MALRD1, MANCR, MAP3K8, MARCHF8, MASTL, MCM10, MCS+9.7, MEIG1, MINDY3, MIR1265, MIR1915, MIR1915HG, MIR3155A, MIR3155B, MIR3156-1, MIR3611, MIR4293, MIR4480, MIR4481, MIR4675, MIR4683, MIR5100, MIR511, MIR548AK, MIR548Q, MIR603, MIR604, MIR7162, MIR8086, MIR938, MKX, MKX-AS1, MLLT10, MPP7, MRC1, MSANTD7, MSMB, MSRB2, MTPAP, MTRNR2L7, MYO3A, NCOA4, NEBL, NEBL-AS1, NET1, NMT2, NPY4R, NPY4R2, NRP1, NSUN6, NUDT5, ODAD2, OLAH, OPTN, OR13A1, OTUD1, PARD3, PARD3-DT, PCAT5, PDSS1, PFKFB3, PHYH, PIP4K2A, PLXDC2, PRINS, PRKCQ, PRKCQ-AS1, PROSER2, PROSER2-AS1, PRPF18, PRTFDC1, PTCHD3, PTER, PTF1A, PTPN20, RAB18, RASGEF1A, RASSF4, RBM17, RBP3, RET, RPP38, RPP38-DT, RSU1, SEC61A2, SEPHS1, SFMBT2, SKIDA1, SLC39A12, SLC39A12-AS1, SNORA74C-1, SNORA86, SNORD129, SNORD130, SNORD3J, SPAG6, ST8SIA6, ST8SIA6-AS1, STAM, STAM-DT, SUV39H2, SUV39H2-DT, SVIL, SVIL-AS1, SYT15, SYT15-AS1, SYT15B, TAF3, TASOR2, THNSL1, TIMM23, TMEM236, TMEM72, TMEM72-AS1, TRDMT1, TRN-GTT2-3, TRV-TAC3-1, TUBAL3, UCMA, UCN3, UPF2, USP6NL, USP6NL-AS1, VIM, VIM-AS1, WAC, WAC-AS1, WASHC2C, YME1L1, ZEB1, ZEB1-AS1, ZFAND4, ZNF22, ZNF22-AS1, ZNF239, ZNF248, ZNF25, ZNF32, ZNF32-AS1, ZNF32-AS2, ZNF32-AS3, ZNF33A, ZNF33B, ZNF37A, ZNF438, ZNF485, ZNF487, ZNF488
See casesBenign
(Feb 4, 2013)
no assertion criteria provided
2.
GRCh37:
Chr10:42607635-69160433
GRCh38:
Chr10:42112187-67400675
LOC121366055, LOC121366056, LOC121366057, LOC121811730, LOC121815939, LOC121815940, LOC121815941, LOC121815942, LOC124403943, LOC124403944, LOC124403945, LOC124403946, LOC124403948, LOC124403949, LOC124403950, LOC124403951, LOC124403952, LOC124403953, LOC124403954, LOC124403955, LOC124403956, LOC124403957, LOC124403958, LOC124403959, LOC124403960, LOC124403961, LOC124403962, LOC124403963, LOC124403966, LOC124403967, LOC124403968, LOC124403969, LOC124403970, LOC126860919, LOC126860920, LOC126860921, LOC126860922, LOC126860923, LOC126860924, LOC126860925, LOC126860926, LOC126860927, LOC126860928, LOC126860929, LOC126860930, LOC126860931, LOC126860932, LOC126860933, LOC126860934, LOC126860935, LOC126860936, LOC126860937, LOC126860938, LOC126860939, LOC126860940, LOC126860941, LOC126860942, LOC126860943, LOC126860944, LOC126860945, LOC126860946, LOC126860947, LOC126860948, LOC283028, LOC283045, LRRC18, LRRTM3, MAPK8, MARCHF8, MBL2, MCS+9.7, MIR1296, MIR3156-1, MIR3924, MIR4294, MIR5100, MIR548F1, MIR605, MRLN, MSMB, MTRNR2L5, NCOA4, NPY4R, NPY4R2, NRBF2, OGDHL, OR13A1, PARG, PCDH15, PGBD3, PHYHIPL, PRKG1, PRKG1-AS1, PTPN20, RASGEF1A, RASSF4, RBP3, REEP3, RET, RHOBTB1, RTKN2, SGMS1, SGMS1-AS1, SLC16A9, SLC18A3, SNORA74C-1, SNORA74C-2, SNORD3J, SYT15, SYT15-AS1, SYT15B, TFAM, TIMM23, TIMM23B, TIMM23B-AGAP6, TMEM26, TMEM26-AS1, TMEM273, TMEM72, TMEM72-AS1, UBE2D1, VSTM4, WASHC2A, WASHC2C, WDFY4, ZFAND4, ZNF22, ZNF22-AS1, ZNF239, ZNF32, ZNF32-AS1, ZNF32-AS2, ZNF32-AS3, ZNF33B, ZNF365, ZNF485, ZNF487, ZNF488, ZWINT, A1CF, ADO, AGAP10, AGAP4, AGAP6, AGAP9, ALOX5, ANK3, ANK3-DT, ANTXRL, ANXA8, ANXA8L1, ARHGAP22, ARHGAP22-IT1, ARID5B, ASAH2, ASAH2B, BICC1, BMS1, C10orf53, C10orf71, C10orf71-AS1, CABCOCO1, CCDC6, CCEPR, CDK1, CHAT, CISD1, CSGALNACT2, CSGALNACT2-DT, CSTF2T, CTNNA3, CXCL12, DEPP1, DKK1, DRGX, EGR2, ERCC6, FAM13C, FAM170B, FAM170B-AS1, FAM245B, FAM25C, FAM25E, FAM25G, FRMPD2, FXYD4, GDF10, GDF2, GPRIN2, HNRNPF, IPMK, JMJD1C, JMJD1C-AS1, JMJD1C-AS2, LINC00619, LINC00839, LINC00840, LINC00841, LINC00842, LINC00844, LINC00845, LINC01264, LINC01515, LINC01518, LINC01553, LINC02621, LINC02623, LINC02632, LINC02637, LINC02658, LINC02659, LINC02671, LINC02672, LINC02881, LINC02916, LINC03029, LNCAROD, LOC101928961, LOC102724323, LOC102724593, LOC102724719, LOC105378269, LOC105378289, LOC105378305, LOC105378311, LOC105378328, LOC105378577, LOC106736614, LOC107001062, LOC107984236, LOC110121478, LOC110121502, LOC110121503, LOC110121506, LOC110121507, LOC111818966, LOC111818967, LOC111946237, LOC111946238, LOC111946239, LOC111946240, LOC111946243, LOC111946244, LOC111946247, LOC111946248, LOC111946249, LOC112268068, LOC113939916, LOC114827857, LOC116216113, LOC121366050, LOC121366051, LOC121366052, LOC121366053, LOC121366054
See casesPathogenic
(Aug 20, 2012)
no assertion criteria provided
3.
GRCh37:
Chr10:42890649-52636819
GRCh38:
Chr10:42395201-50877059
A1CF, AGAP10, AGAP4, AGAP6, AGAP9, ALOX5, ANTXRL, ANXA8, ANXA8L1, ARHGAP22, ARHGAP22-IT1, ASAH2, ASAH2B, BMS1, C10orf53, C10orf71, C10orf71-AS1, CHAT, CSGALNACT2, CSGALNACT2-DT, CXCL12, DEPP1, DRGX, ERCC6, FAM170B, FAM170B-AS1, FAM245B, FAM25C, FAM25E, FAM25G, FRMPD2, FXYD4, GDF10, GDF2, GPRIN2, HNRNPF, LINC00619, LINC00839, LINC00840, LINC00841, LINC00842, LINC01264, LINC01518, LINC02623, LINC02632, LINC02637, LINC02658, LINC02659, LINC02881, LINC02916, LINC03029, LOC102724323, LOC102724593, LOC105378269, LOC105378289, LOC105378577, LOC106736614, LOC107001062, LOC110121478, LOC110121502, LOC110121503, LOC110121506, LOC110121507, LOC111818966, LOC111818967, LOC111946237, LOC111946238, LOC111946239, LOC111946240, LOC111946243, LOC111946244, LOC113939916, LOC114827857, LOC121366050, LOC121366051, LOC121366052, LOC121366053, LOC121366054, LOC121366055, LOC121811730, LOC124403943, LOC124403944, LOC124403945, LOC124403946, LOC124403948, LOC124403949, LOC124403950, LOC124403951, LOC124403952, LOC124403953, LOC124403954, LOC124403955, LOC126860919, LOC126860920, LOC126860921, LOC126860922, LOC126860923, LOC126860924, LOC126860925, LOC126860926, LOC126860927, LOC126860928, LOC126860929, LOC126860930, LOC126860931, LOC126860932, LOC126860933, LOC283028, LRRC18, MAPK8, MARCHF8, MCS+9.7, MIR3156-1, MIR4294, MIR5100, MSMB, NCOA4, NPY4R, NPY4R2, OGDHL, OR13A1, PARG, PGBD3, PTPN20, RASGEF1A, RASSF4, RBP3, RET, SGMS1, SGMS1-AS1, SLC18A3, SNORA74C-1, SNORA74C-2, SNORD3J, SYT15, SYT15-AS1, SYT15B, TIMM23, TIMM23B, TIMM23B-AGAP6, TMEM273, TMEM72, TMEM72-AS1, VSTM4, WASHC2A, WASHC2C, WDFY4, ZFAND4, ZNF22, ZNF22-AS1, ZNF239, ZNF32, ZNF32-AS1, ZNF32-AS2, ZNF32-AS3, ZNF33B, ZNF485, ZNF487, ZNF488
See casesPathogenic
(Sep 30, 2010)
no assertion criteria provided
4.
GRCh37:
Chr10:42890664-43729688
GRCh38:
Chr10:42395216-43234240
See casesUncertain significance
(Dec 22, 2010)
no assertion criteria provided
5.
GRCh37:
Chr10:43180754-75475666
GRCh38:
Chr10:42685306-73715908
SLC18A3, SLC25A16, SLC29A3, SNORA11F, SNORA74C-1, SNORA74C-2, SNORD3J, SNORD98, SPOCK2, SRGN, STOX1, SUPV3L1, SYNPO2L, SYNPO2L-AS1, SYT15, SYT15-AS1, SYT15B, TACR2, TBATA, TET1, TFAM, TIMM23, TIMM23B, TIMM23B-AGAP6, TMEM26, TMEM26-AS1, TMEM273, TMEM72, TMEM72-AS1, TRS-TGA1-1, TSPAN15, TYSND1, UBE2D1, UNC5B, UNC5B-AS1, USP54, VPS26A, VSIR, VSTM4, WASHC2A, WASHC2C, WDFY4, ZFAND4, ZNF22, ZNF22-AS1, ZNF239, ZNF32, ZNF32-AS1, ZNF32-AS2, ZNF32-AS3, ZNF365, ZNF485, ZNF487, ZNF488, ZWINT, A1CF, ADAMTS14, ADO, AGAP10, AGAP4, AGAP5, AGAP6, AGAP9, AIFM2, ALOX5, ANAPC16, ANK3, ANK3-DT, ANTXRL, ANXA7, ANXA8, ANXA8L1, ARHGAP22, ARHGAP22-IT1, ARID5B, ASAH2, ASAH2B, ASCC1, ATOH7, BICC1, BMS1, C10orf105, C10orf53, C10orf71, C10orf71-AS1, CABCOCO1, CCAR1, CCDC6, CCEPR, CDH23, CDH23-AS1, CDK1, CFAP70, CHAT, CHST3, CISD1, COL13A1, CSGALNACT2, CSGALNACT2-DT, CSTF2T, CTNNA3, CXCL12, DDIT4, DDX21, DDX50, DEPP1, DKK1, DNA2, DNAJB12, DNAJC12, DNAJC9, DNAJC9-AS1, DRGX, ECD, EGR2, EIF4EBP2, ERCC6, FAM13C, FAM149B1, FAM170B, FAM170B-AS1, FAM241B, FAM245B, FAM25C, FAM25E, FAM25G, FRMPD2, FXYD4, GDF10, GDF2, GPRIN2, HERC4, HK1, HKDC1, HNRNPF, HNRNPH3, IPMK, JMJD1C, JMJD1C-AS1, JMJD1C-AS2, KIFBP, LINC00619, LINC00840, LINC00841, LINC00842, LINC00844, LINC00845, LINC01264, LINC01515, LINC01518, LINC01553, LINC02621, LINC02622, LINC02623, LINC02632, LINC02636, LINC02637, LINC02651, LINC02658, LINC02659, LINC02671, LINC02672, LINC02881, LINC02916, LINC03029, LNCAROD, LOC101928961, LOC101928994, LOC102724323, LOC102724593, LOC102724719, LOC105378269, LOC105378289, LOC105378305, LOC105378311, LOC105378328, LOC105378577, LOC106736614, LOC107001062, LOC107832851, LOC107984236, LOC108178982, LOC110121478, LOC110121502, LOC110121503, LOC110121506, LOC110121507, LOC111365158, LOC111365196, LOC111818966, LOC111818967, LOC111946237, LOC111946238, LOC111946239, LOC111946240, LOC111946243, LOC111946244, LOC111946247, LOC111946248, LOC111946249, LOC111946250, LOC111949323, LOC111982863, LOC111982864, LOC111982865, LOC111982866, LOC111982867, LOC111982868, LOC111982869, LOC111982870, LOC112268068, LOC113939916, LOC114827857, LOC116216113, LOC116216114, LOC120807611, LOC121366050, LOC121366051, LOC121366052, LOC121366053, LOC121366054, LOC121366055, LOC121366056, LOC121366057, LOC121366058, LOC121366059, LOC121366060, LOC121366061, LOC121366062, LOC121811730, LOC121815939, LOC121815940, LOC121815941, LOC121815942, LOC121815943, LOC121815944, LOC121815945, LOC121815946, LOC121815947, LOC121815948, LOC121815949, LOC124403944, LOC124403945, LOC124403946, LOC124403948, LOC124403949, LOC124403950, LOC124403951, LOC124403952, LOC124403953, LOC124403954, LOC124403955, LOC124403956, LOC124403957, LOC124403958, LOC124403959, LOC124403960, LOC124403961, LOC124403962, LOC124403963, LOC124403966, LOC124403967, LOC124403968, LOC124403969, LOC124403970, LOC124403971, LOC124403972, LOC124403973, LOC124403974, LOC124403975, LOC124403976, LOC124416833, LOC124416834, LOC124416835, LOC124416836, LOC124416837, LOC124416838, LOC124416839, LOC126860919, LOC126860920, LOC126860921, LOC126860922, LOC126860923, LOC126860924, LOC126860925, LOC126860926, LOC126860927, LOC126860928, LOC126860929, LOC126860930, LOC126860931, LOC126860932, LOC126860933, LOC126860934, LOC126860935, LOC126860936, LOC126860937, LOC126860938, LOC126860939, LOC126860940, LOC126860941, LOC126860942, LOC126860943, LOC126860944, LOC126860945, LOC126860946, LOC126860947, LOC126860948, LOC126860949, LOC126860950, LOC126860951, LOC126860952, LOC126860953, LOC126860954, LOC126860955, LOC283028, LOC283045, LRRC18, LRRC20, LRRTM3, MACROH2A2, MAPK8, MARCHF8, MBL2, MCS+9.7, MCU, MICU1, MIR1296, MIR3156-1, MIR3924, MIR4294, MIR4676, MIR5100, MIR548F1, MIR605, MIR7151, MIR7152, MRLN, MRPS16, MSMB, MSS51, MTRNR2L5, MYOZ1, MYPN, NCOA4, NEUROG3, NODAL, NPFFR1, NPY4R, NPY4R2, NRBF2, NUDT13, OGDHL, OIT3, OR13A1, P4HA1, PALD1, PARG, PBLD, PCBD1, PCDH15, PGBD3, PHYHIPL, PLA2G12B, PPA1, PPP3CB, PPP3CB-AS1, PRF1, PRKG1, PRKG1-AS1, PSAP, PTPN20, RASGEF1A, RASSF4, RBP3, REEP3, RET, RHOBTB1, RTKN2, RUFY2, SAR1A, SGMS1, SGMS1-AS1, SGPL1, SIRT1, SLC16A9
See casesPathogenic
(Sep 30, 2010)
no assertion criteria provided
6.
GRCh37:
Chr10:43379742-54025077
GRCh38:
Chr10:42884294-52265317
A1CF, AGAP10, AGAP4, AGAP6, AGAP9, ALOX5, ANTXRL, ANXA8, ANXA8L1, ARHGAP22, ARHGAP22-IT1, ASAH2, ASAH2B, C10orf53, C10orf71, C10orf71-AS1, CHAT, CSGALNACT2, CSGALNACT2-DT, CSTF2T, CXCL12, DEPP1, DRGX, ERCC6, FAM170B, FAM170B-AS1, FAM245B, FAM25C, FAM25E, FAM25G, FRMPD2, FXYD4, GDF10, GDF2, GPRIN2, HNRNPF, LINC00619, LINC00840, LINC00841, LINC00842, LINC01264, LINC02637, LINC02658, LINC02659, LINC02881, LINC02916, LINC03029, LOC102724323, LOC102724593, LOC102724719, LOC105378289, LOC105378577, LOC106736614, LOC107001062, LOC110121478, LOC110121502, LOC110121503, LOC110121506, LOC110121507, LOC111818966, LOC111818967, LOC111946237, LOC111946238, LOC111946239, LOC111946240, LOC111946243, LOC111946244, LOC113939916, LOC114827857, LOC121366050, LOC121366051, LOC121366052, LOC121366053, LOC121366054, LOC121366055, LOC121811730, LOC124403945, LOC124403946, LOC124403948, LOC124403949, LOC124403950, LOC124403951, LOC124403952, LOC124403953, LOC124403954, LOC124403955, LOC124403956, LOC124403957, LOC126860919, LOC126860920, LOC126860921, LOC126860922, LOC126860923, LOC126860924, LOC126860925, LOC126860926, LOC126860927, LOC126860928, LOC126860929, LOC126860930, LOC126860931, LOC126860932, LOC126860933, LRRC18, MAPK8, MARCHF8, MCS+9.7, MIR3156-1, MIR4294, MIR5100, MIR605, MSMB, NCOA4, NPY4R, NPY4R2, OGDHL, OR13A1, PARG, PGBD3, PRKG1, PTPN20, RASGEF1A, RASSF4, RBP3, RET, SGMS1, SGMS1-AS1, SLC18A3, SNORA74C-1, SNORA74C-2, SNORD3J, SYT15, SYT15-AS1, SYT15B, TIMM23, TIMM23B, TIMM23B-AGAP6, TMEM273, TMEM72, TMEM72-AS1, VSTM4, WASHC2A, WASHC2C, WDFY4, ZFAND4, ZNF22, ZNF22-AS1, ZNF239, ZNF32, ZNF32-AS1, ZNF32-AS2, ZNF32-AS3, ZNF485, ZNF487, ZNF488
See casesPathogenic
(Nov 30, 2010)
no assertion criteria provided
7.
GRCh37:
Chr10:43572180
GRCh38:
Chr10:43076732
LOC106736614, RETnot providedLikely benign
(Feb 24, 2019)
criteria provided, single submitter
8.
GRCh37:
Chr10:43572296
GRCh38:
Chr10:43076848
LOC106736614, RETnot providedBenign
(May 6, 2019)
criteria provided, single submitter
9.
GRCh37:
Chr10:43572426
GRCh38:
Chr10:43076978
LOC106736614, RETnot providedLikely benign
(Apr 1, 2020)
criteria provided, single submitter
10.
GRCh37:
Chr10:43572458-43572459
GRCh38:
Chr10:43077010-43077011
LOC106736614, RETMultiple endocrine neoplasia, type 2aUncertain significance
(Aug 18, 2011)
criteria provided, single submitter
11.
GRCh37:
Chr10:43572481
GRCh38:
Chr10:43077033
LOC106736614, RETnot providedLikely benign
(Jun 21, 2018)
criteria provided, single submitter
12.
GRCh37:
Chr10:43572507
GRCh38:
Chr10:43077059
LOC106736614, RETHirschsprung Disease, Dominant, Renal hypodysplasia/aplasia 1, Pheochromocytoma,
Multiple endocrine neoplasia, not provided
Benign
(Jun 24, 2018)
criteria provided, multiple submitters, no conflicts
13.
GRCh37:
Chr10:43572511
GRCh38:
Chr10:43077063
LOC106736614, RETnot provided, Hirschsprung Disease, Dominant, Multiple endocrine neoplasia,
Renal hypodysplasia/aplasia 1, Pheochromocytoma
Benign/Likely benign
(Jun 15, 2018)
criteria provided, multiple submitters, no conflicts
14.
GRCh37:
Chr10:43572520
GRCh38:
Chr10:43077072
LOC106736614, RETMultiple endocrine neoplasia, Hirschsprung Disease, Dominant, Pheochromocytoma,
Renal hypodysplasia/aplasia 1
Uncertain significance
(Jun 14, 2016)
criteria provided, single submitter
15.
GRCh37:
Chr10:43572534
GRCh38:
Chr10:43077086
LOC106736614, RETPheochromocytoma, Renal hypodysplasia/aplasia 1, Hirschsprung disease, susceptibility to, 1,
Multiple endocrine neoplasia
Uncertain significance
(Jan 13, 2018)
criteria provided, single submitter
16.
GRCh37:
Chr10:43572547
GRCh38:
Chr10:43077099
LOC106736614, RETRenal hypodysplasia/aplasia 1, Hirschsprung disease, susceptibility to, 1, Pheochromocytoma,
Multiple endocrine neoplasia
Benign/Likely benign
(Jul 18, 2017)
criteria provided, single submitter
17.
GRCh37:
Chr10:43572549
GRCh38:
Chr10:43077101
LOC106736614, RETMultiple endocrine neoplasia, Pheochromocytoma, Renal hypodysplasia/aplasia 1,
Hirschsprung disease, susceptibility to, 1
Uncertain significance
(Jan 12, 2018)
criteria provided, single submitter
18.
GRCh37:
Chr10:43572575
GRCh38:
Chr10:43077127
LOC106736614, RETMultiple endocrine neoplasia, Pheochromocytoma, Hereditary cancer-predisposing syndrome,
Renal hypodysplasia/aplasia 1, Hirschsprung disease, susceptibility to, 1
Conflicting interpretations of pathogenicity
(Jun 1, 2021)
criteria provided, conflicting interpretations
19.
GRCh37:
Chr10:43572639
GRCh38:
Chr10:43077191
LOC106736614, RETnot providedBenign
(Mar 3, 2015)
criteria provided, single submitter
20.
GRCh37:
Chr10:43572656
GRCh38:
Chr10:43077208
LOC106736614, RETHirschsprung disease, susceptibility to, 1, Renal hypodysplasia/aplasia 1, Pheochromocytoma,
Multiple endocrine neoplasia
Uncertain significance
(Jan 12, 2018)
criteria provided, single submitter
21.
GRCh37:
Chr10:43572670
GRCh38:
Chr10:43077222
RET, LOC106736614not provided, Multiple endocrine neoplasia, type 2Conflicting interpretations of pathogenicity
(Feb 19, 2022)
criteria provided, conflicting interpretations
22.
GRCh37:
Chr10:43572697-43623727
GRCh38:
Chr10:43077249-43128279
LOC106736614, LOC110121502, MCS+9.7, RETMultiple endocrine neoplasia, type 2Uncertain significance
(Apr 3, 2019)
criteria provided, single submitter
23.
GRCh37:
Chr10:43572700-43572703
GRCh38:
Chr10:43077252-43077255
LOC106736614, RETHereditary cancer-predisposing syndromeUncertain significance
(Jul 26, 2022)
criteria provided, single submitter
24.
GRCh37:
Chr10:43572701
GRCh38:
Chr10:43077253
LOC106736614, RETnot providedUncertain significance
(May 13, 2021)
criteria provided, single submitter
25.
GRCh37:
Chr10:43572701-43623723
GRCh38:
Chr10:43077253-43128275
LOC106736614, LOC110121502, MCS+9.7, RETMultiple endocrine neoplasia, type 2Uncertain significance
(Mar 7, 2017)
criteria provided, single submitter
26.
GRCh37:
Chr10:43572702-43572703
GRCh38:
Chr10:43077254-43077255
LOC106736614, RETHereditary cancer-predisposing syndromeLikely benign
(Jan 5, 2023)
criteria provided, single submitter
27.
GRCh37:
Chr10:43572702
GRCh38:
Chr10:43077254
LOC106736614, RETHereditary cancer-predisposing syndromeUncertain significance
(Sep 2, 2020)
criteria provided, single submitter
28.
GRCh37:
Chr10:43572703
GRCh38:
Chr10:43077255
LOC106736614, RETHereditary cancer-predisposing syndromeUncertain significance
(Jun 30, 2022)
criteria provided, single submitter
29.
GRCh37:
Chr10:43572704
GRCh38:
Chr10:43077256
LOC106736614, RETHereditary cancer-predisposing syndromeUncertain significance
(Dec 4, 2020)
criteria provided, single submitter
30.
GRCh37:
Chr10:43572705
GRCh38:
Chr10:43077257
LOC106736614, RETHereditary cancer-predisposing syndrome, not provided, Pheochromocytoma,
Multiple endocrine neoplasia, type 2a, Hirschsprung disease, susceptibility to, 1, Multiple endocrine neoplasia, type 2b,
Familial medullary thyroid carcinoma, not specified
Conflicting interpretations of pathogenicity
(May 6, 2022)
criteria provided, conflicting interpretations
31.
GRCh37:
Chr10:43572706
GRCh38:
Chr10:43077258
LOC106736614, RETHereditary cancer-predisposing syndromeUncertain significance
(Jan 17, 2020)
criteria provided, single submitter
32.
GRCh37:
Chr10:43572708-43572709
GRCh38:
Chr10:43077260-43077261
LOC106736614, RETMultiple endocrine neoplasia, type 2, Hereditary cancer-predisposing syndrome, not specified
Uncertain significance
(Aug 15, 2023)
criteria provided, multiple submitters, no conflicts
33.
GRCh37:
Chr10:43572712
GRCh38:
Chr10:43077264
LOC106736614, RETHereditary cancer-predisposing syndrome, Multiple endocrine neoplasia, type 2Likely benign
(Aug 30, 2022)
criteria provided, multiple submitters, no conflicts
34.
GRCh37:
Chr10:43572713
GRCh38:
Chr10:43077265
LOC106736614, RETK3EMultiple endocrine neoplasia, type 2, Hereditary cancer-predisposing syndromeUncertain significance
(Sep 19, 2022)
criteria provided, multiple submitters, no conflicts
35.
GRCh37:
Chr10:43572716
GRCh38:
Chr10:43077268
LOC106736614, RETA4TMultiple endocrine neoplasia, type 2Uncertain significance
(Feb 8, 2022)
criteria provided, single submitter
36.
GRCh37:
Chr10:43572717
GRCh38:
Chr10:43077269
LOC106736614, RETA4VMultiple endocrine neoplasia, type 2Uncertain significance
(Jun 6, 2022)
criteria provided, single submitter
37.
GRCh37:
Chr10:43572719
GRCh38:
Chr10:43077271
RET, LOC106736614T5AHereditary cancer-predisposing syndrome, Multiple endocrine neoplasia, type 2Uncertain significance
(Aug 23, 2022)
criteria provided, multiple submitters, no conflicts
38.
GRCh37:
Chr10:43572720
GRCh38:
Chr10:43077272
LOC106736614, RETT5MHereditary cancer-predisposing syndrome, Multiple endocrine neoplasia, type 2Uncertain significance
(Sep 19, 2022)
criteria provided, multiple submitters, no conflicts
39.
GRCh37:
Chr10:43572720
GRCh38:
Chr10:43077272
LOC106736614, RETT5RMultiple endocrine neoplasia, type 2Uncertain significance
(Sep 1, 2021)
criteria provided, single submitter
40.
GRCh37:
Chr10:43572721
GRCh38:
Chr10:43077273
LOC106736614, RETMultiple endocrine neoplasia, type 2Likely benign
(May 27, 2022)
criteria provided, single submitter
41.
GRCh37:
Chr10:43572721
GRCh38:
Chr10:43077273
LOC106736614, RETHereditary cancer-predisposing syndromeLikely benign
(Oct 6, 2019)
criteria provided, single submitter
42.
GRCh37:
Chr10:43572721
GRCh38:
Chr10:43077273
LOC106736614, RETMultiple endocrine neoplasia, type 2, Hereditary cancer-predisposing syndromeLikely benign
(Jul 11, 2022)
criteria provided, multiple submitters, no conflicts
43.
GRCh37:
Chr10:43572722
GRCh38:
Chr10:43077274
LOC106736614, RETS6PMultiple endocrine neoplasia, type 2Uncertain significance
(Aug 27, 2021)
criteria provided, single submitter
44.
GRCh37:
Chr10:43572722
GRCh38:
Chr10:43077274
LOC106736614, RETS6AMultiple endocrine neoplasia, type 2Uncertain significance
(Aug 28, 2021)
criteria provided, single submitter
45.
GRCh37:
Chr10:43572724
GRCh38:
Chr10:43077276
LOC106736614, RETHereditary cancer-predisposing syndromeLikely benign
(Oct 17, 2022)
criteria provided, single submitter
46.
GRCh37:
Chr10:43572724
GRCh38:
Chr10:43077276
LOC106736614, RETHereditary cancer-predisposing syndromeLikely benign
(Dec 26, 2019)
criteria provided, single submitter
47.
GRCh37:
Chr10:43572724
GRCh38:
Chr10:43077276
LOC106736614, RETMultiple endocrine neoplasia, type 2, not provided, Hereditary cancer-predisposing syndrome
Conflicting interpretations of pathogenicity
(Sep 23, 2022)
criteria provided, conflicting interpretations
48.
GRCh37:
Chr10:43572725
GRCh38:
Chr10:43077277
LOC106736614, RETG7SMultiple endocrine neoplasia, type 2Uncertain significance
(Aug 19, 2022)
criteria provided, single submitter
49.
GRCh37:
Chr10:43572726
GRCh38:
Chr10:43077278
LOC106736614, RETG7VMultiple endocrine neoplasia, type 2Uncertain significance
(Aug 28, 2021)
criteria provided, single submitter
50.
GRCh37:
Chr10:43572726
GRCh38:
Chr10:43077278
LOC106736614, RETG7DHereditary cancer-predisposing syndrome, Multiple endocrine neoplasia, type 2, not provided,
Multiple endocrine neoplasia, type 2b, Multiple endocrine neoplasia, type 2a, Pheochromocytoma,
Familial medullary thyroid carcinoma, Hirschsprung disease, susceptibility to, 1
Uncertain significance
(Sep 15, 2023)
criteria provided, multiple submitters, no conflicts
51.
GRCh37:
Chr10:43572727
GRCh38:
Chr10:43077279
LOC106736614, RETHereditary cancer-predisposing syndromeLikely benign
(May 23, 2023)
criteria provided, single submitter
52.
GRCh37:
Chr10:43572728
GRCh38:
Chr10:43077280
LOC106736614, RETA8SMultiple endocrine neoplasia, type 2, Hereditary cancer-predisposing syndromeUncertain significance
(Mar 26, 2022)
criteria provided, multiple submitters, no conflicts
53.
GRCh37:
Chr10:43572729
GRCh38:
Chr10:43077281
LOC106736614, RETA8VHereditary cancer-predisposing syndromeUncertain significance
(May 13, 2022)
criteria provided, single submitter
54.
GRCh37:
Chr10:43572730
GRCh38:
Chr10:43077282
LOC106736614, RETHereditary cancer-predisposing syndromeLikely benign
(Dec 22, 2021)
criteria provided, single submitter
55.
GRCh37:
Chr10:43572733
GRCh38:
Chr10:43077285
LOC106736614, RETHereditary cancer-predisposing syndromeLikely benign
(Oct 5, 2021)
criteria provided, single submitter
56.
GRCh37:
Chr10:43572733
GRCh38:
Chr10:43077285
LOC106736614, RETHereditary cancer-predisposing syndromeLikely benign
(May 3, 2022)
criteria provided, single submitter
57.
GRCh37:
Chr10:43572735
GRCh38:
Chr10:43077287
LOC106736614, RETG10AMultiple endocrine neoplasia, type 2Uncertain significance
(Aug 14, 2021)
criteria provided, single submitter
58.
GRCh37:
Chr10:43572735-43572736
GRCh38:
Chr10:43077287-43077288
LOC106736614, RETHereditary cancer-predisposing syndrome, Multiple endocrine neoplasia, type 2Uncertain significance
(Apr 21, 2022)
criteria provided, multiple submitters, no conflicts
59.
GRCh37:
Chr10:43572735-43572736
GRCh38:
Chr10:43077287-43077288
LOC106736614, RETMultiple endocrine neoplasia, type 2, Hereditary cancer-predisposing syndromeUncertain significance
(Oct 27, 2022)
criteria provided, multiple submitters, no conflicts
60.
GRCh37:
Chr10:43572735
GRCh38:
Chr10:43077287
LOC106736614, RETG10EHereditary cancer-predisposing syndrome, Multiple endocrine neoplasia, type 2Uncertain significance
(Aug 31, 2021)
criteria provided, multiple submitters, no conflicts
61.
GRCh37:
Chr10:43572735
GRCh38:
Chr10:43077287
LOC106736614, RETG10VMultiple endocrine neoplasia, type 2Uncertain significance
(Apr 10, 2022)
criteria provided, single submitter
62.
GRCh37:
Chr10:43572736
GRCh38:
Chr10:43077288
LOC106736614, RETMultiple endocrine neoplasia, type 2Uncertain significance
(Aug 20, 2021)
criteria provided, single submitter
63.
GRCh37:
Chr10:43572736
GRCh38:
Chr10:43077288
LOC106736614, RETMultiple endocrine neoplasia, type 2, Hereditary cancer-predisposing syndromeLikely benign
(Sep 3, 2022)
criteria provided, multiple submitters, no conflicts
64.
GRCh37:
Chr10:43572737
GRCh38:
Chr10:43077289
LOC106736614, RETL11MHereditary cancer-predisposing syndrome, not specified, Multiple endocrine neoplasia, type 2
Conflicting interpretations of pathogenicity
(Sep 19, 2022)
criteria provided, conflicting interpretations
65.
GRCh37:
Chr10:43572737
GRCh38:
Chr10:43077289
LOC106736614, RETHereditary cancer-predisposing syndrome, Multiple endocrine neoplasia, type 2b, Pheochromocytoma,
Hirschsprung disease, susceptibility to, 1, Familial medullary thyroid carcinoma, Multiple endocrine neoplasia, type 2a,
Multiple endocrine neoplasia, type 2
Likely benign
(Sep 14, 2022)
criteria provided, multiple submitters, no conflicts
66.
GRCh37:
Chr10:43572737
GRCh38:
Chr10:43077289
LOC106736614, RETL11VMultiple endocrine neoplasia, type 2, Hereditary cancer-predisposing syndromeUncertain significance
(Aug 24, 2021)
criteria provided, multiple submitters, no conflicts
67.
GRCh37:
Chr10:43572740
GRCh38:
Chr10:43077292
RETR12GMultiple endocrine neoplasia, type 2Uncertain significance
(Sep 2, 2021)
criteria provided, single submitter
68.
GRCh37:
Chr10:43572741
GRCh38:
Chr10:43077293
RETR12HMultiple endocrine neoplasia, type 2Uncertain significance
(Aug 6, 2021)
criteria provided, single submitter
69.
GRCh37:
Chr10:43572742-43572743
GRCh38:
Chr10:43077294-43077295
RETMultiple endocrine neoplasia, type 2, Hereditary cancer-predisposing syndromeConflicting interpretations of pathogenicity
(Sep 6, 2022)
criteria provided, conflicting interpretations
70.
GRCh37:
Chr10:43572743-43572744
GRCh38:
Chr10:43077295-43077296
RETMultiple endocrine neoplasia, type 2Uncertain significance
(Aug 28, 2021)
criteria provided, single submitter
71.
GRCh37:
Chr10:43572743-43572751
GRCh38:
Chr10:43077295-43077303
RETMultiple endocrine neoplasia, type 2, Hereditary cancer-predisposing syndromeConflicting interpretations of pathogenicity
(Sep 25, 2021)
criteria provided, conflicting interpretations
72.
GRCh37:
Chr10:43572745
GRCh38:
Chr10:43077297
RETMultiple endocrine neoplasia, type 2Likely benign
(Oct 18, 2022)
criteria provided, single submitter
73.
GRCh37:
Chr10:43572745
GRCh38:
Chr10:43077297
RETHereditary cancer-predisposing syndromeLikely benign
(Aug 23, 2022)
criteria provided, single submitter
74.
GRCh37:
Chr10:43572747-43572749
GRCh38:
Chr10:43077299-43077301
RETHereditary cancer-predisposing syndromeUncertain significance
(Oct 29, 2020)
criteria provided, single submitter
75.
GRCh37:
Chr10:43572747
GRCh38:
Chr10:43077299
RETL14PMultiple endocrine neoplasia, type 2Uncertain significance
(Aug 27, 2021)
criteria provided, single submitter
76.
GRCh37:
Chr10:43572749-43572750
GRCh38:
Chr10:43077301-43077302
RETMultiple endocrine neoplasia, type 2Uncertain significance
(Aug 20, 2021)
criteria provided, single submitter
77.
GRCh37:
Chr10:43572749-43572750
GRCh38:
Chr10:43077301-43077302
RETMultiple endocrine neoplasia, type 2, Hereditary cancer-predisposing syndromeConflicting interpretations of pathogenicity
(Dec 23, 2022)
criteria provided, conflicting interpretations
78.
GRCh37:
Chr10:43572749
GRCh38:
Chr10:43077301
RETHereditary cancer-predisposing syndrome, Multiple endocrine neoplasia, type 2Likely benign
(Aug 14, 2021)
criteria provided, multiple submitters, no conflicts
79.
GRCh37:
Chr10:43572749-43572750
GRCh38:
Chr10:43077301-43077302
RETHereditary cancer-predisposing syndrome, Multiple endocrine neoplasia, type 2Conflicting interpretations of pathogenicity
(Jun 15, 2022)
criteria provided, conflicting interpretations
80.
GRCh37:
Chr10:43572749-43572750
GRCh38:
Chr10:43077301-43077302
RETnot provided, not specified, Hereditary cancer-predisposing syndrome,
Multiple endocrine neoplasia, type 2a, Multiple endocrine neoplasia, type 2, Multiple endocrine neoplasia, type 2b,
Hirschsprung disease, susceptibility to, 1, Pheochromocytoma, Familial medullary thyroid carcinoma,
Multiple endocrine neoplasia, type 2a
Conflicting interpretations of pathogenicity
(Feb 27, 2023)
criteria provided, conflicting interpretations
81.
GRCh37:
Chr10:43572750-43572758
GRCh38:
Chr10:43077302-43077310
RETHereditary cancer-predisposing syndromeLikely benign
(Dec 23, 2022)
criteria provided, single submitter
82.
GRCh37:
Chr10:43572750-43572751
GRCh38:
Chr10:43077302-43077303
RETL16fsHereditary cancer-predisposing syndromePathogenic
(Aug 31, 2022)
criteria provided, single submitter
83.
GRCh37:
Chr10:43572750
GRCh38:
Chr10:43077302
RETL15SMultiple endocrine neoplasia, type 2Uncertain significance
(Aug 24, 2021)
criteria provided, single submitter
84.
GRCh37:
Chr10:43572750-43572755
GRCh38:
Chr10:43077302-43077307
RETHereditary cancer-predisposing syndrome, Multiple endocrine neoplasia, type 2Conflicting interpretations of pathogenicity
(Oct 13, 2022)
criteria provided, conflicting interpretations
85.
GRCh37:
Chr10:43572762-43572764
GRCh38:
Chr10:43077302-43077304
RETL19delMultiple endocrine neoplasia, type 2, Multiple endocrine neoplasia, type 2a, Hereditary cancer-predisposing syndrome
Conflicting interpretations of pathogenicity
(Jan 27, 2022)
criteria provided, conflicting interpretations
86.
GRCh37:
Chr10:43572751
GRCh38:
Chr10:43077303
RETnot provided, Hereditary cancer-predisposing syndrome, Multiple endocrine neoplasia, type 2
Likely benign
(Sep 5, 2022)
criteria provided, multiple submitters, no conflicts
87.
GRCh37:
Chr10:43572752
GRCh38:
Chr10:43077304
RETMultiple endocrine neoplasia, type 2, Hereditary cancer-predisposing syndromeLikely benign
(Sep 13, 2022)
criteria provided, multiple submitters, no conflicts
88.
GRCh37:
Chr10:43572753
GRCh38:
Chr10:43077305
RETL16QHereditary cancer-predisposing syndrome, Multiple endocrine neoplasia, type 2Uncertain significance
(Nov 2, 2022)
criteria provided, multiple submitters, no conflicts
89.
GRCh37:
Chr10:43572754
GRCh38:
Chr10:43077306
RETMultiple endocrine neoplasia, type 2, Hereditary cancer-predisposing syndromeLikely benign
(Mar 20, 2022)
criteria provided, multiple submitters, no conflicts
90.
GRCh37:
Chr10:43572755
GRCh38:
Chr10:43077307
RETL17MHereditary cancer-predisposing syndromeUncertain significance
(Mar 11, 2022)
criteria provided, single submitter
91.
GRCh37:
Chr10:43572755
GRCh38:
Chr10:43077307
RETHereditary cancer-predisposing syndrome, Multiple endocrine neoplasia, type 2Likely benign
(Oct 18, 2022)
criteria provided, multiple submitters, no conflicts
92.
GRCh37:
Chr10:43572756
GRCh38:
Chr10:43077308
RETL17PMultiple endocrine neoplasia, type 2, Breast carcinoma, Family history of cancer
Uncertain significance
(Jan 24, 2022)
criteria provided, multiple submitters, no conflicts
93.
GRCh37:
Chr10:43572756-43572757
GRCh38:
Chr10:43077308-43077309
RETHereditary cancer-predisposing syndrome, Multiple endocrine neoplasia, type 2Uncertain significance
(Apr 4, 2023)
criteria provided, multiple submitters, no conflicts
94.
GRCh37:
Chr10:43572757
GRCh38:
Chr10:43077309
RETHereditary cancer-predisposing syndrome, Multiple endocrine neoplasia, type 2Likely benign
(Aug 24, 2022)
criteria provided, multiple submitters, no conflicts
95.
GRCh37:
Chr10:43572758
GRCh38:
Chr10:43077310
RETMultiple endocrine neoplasia, type 2Likely benign
(Jun 17, 2020)
criteria provided, single submitter
96.
GRCh37:
Chr10:43572759
GRCh38:
Chr10:43077311
RETL18PHereditary cancer-predisposing syndrome, Multiple endocrine neoplasia, type 2Uncertain significance
(Aug 31, 2022)
criteria provided, multiple submitters, no conflicts
97.
GRCh37:
Chr10:43572760
GRCh38:
Chr10:43077312
RETHereditary cancer-predisposing syndromeLikely benign
(Feb 7, 2022)
criteria provided, single submitter
98.
GRCh37:
Chr10:43572761
GRCh38:
Chr10:43077313
RETL19MHereditary cancer-predisposing syndromeUncertain significance
(Feb 7, 2022)
criteria provided, single submitter
99.
GRCh37:
Chr10:43572762
GRCh38:
Chr10:43077314
RETL19PHereditary cancer-predisposing syndrome, Multiple endocrine neoplasia, type 2Uncertain significance
(Dec 18, 2022)
criteria provided, multiple submitters, no conflicts
100.
GRCh37:
Chr10:43572762-43572763
GRCh38:
Chr10:43077314-43077315
RETMultiple endocrine neoplasia, type 2, Hereditary cancer-predisposing syndrome, not provided
Uncertain significance
(Oct 18, 2022)
criteria provided, multiple submitters, no conflicts
Format
Items per page
Sort by
Choose Destination